Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-1995 | 07-1995 | 04-1995 | 01-1995 | 10-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 5,688 | 5,899 | 6,549 | 5,545 | 5,588 |
| TOTAL | $5,688 | $5,899 | $6,549 | $5,545 | $5,588 |
| Non-Current Assets | |||||
| PPE Net | 28,026 | 24,887 | 21,350 | N/A | 15,248 |
| Other Non-Current Assets | 3,901 | 3,982 | 4,205 | 4,233 | 4,143 |
| TOTAL | $31,927 | $28,869 | $25,555 | $4,233 | $19,391 |
| Total Assets | $37,615 | $34,768 | $32,104 | $9,778 | $24,979 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,813 | 24,757 | 23,040 | 0 | 11,564 |
| Accounts payable and accrued liabilities | 12,724 | 12,809 | 9,850 | 7,884 | 7,731 |
| Accrued Expenses | 6,896 | 7,769 | 7,048 | 6,106 | 7,207 |
| TOTAL | $38,141 | $45,335 | $39,938 | $33,261 | $26,502 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 577 | 608 | 639 | 669 | 699 |
| TOTAL | $2,153 | $1,969 | $2,004 | $2,035 | $2,067 |
| Total Liabilities | $40,294 | $47,304 | $41,942 | $35,296 | $28,569 |
| Shareholders' Equity | |||||
| Common Shares | 55 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -6,562 | -6,541 | -6,691 | -6,844 | -7,108 |
| TOTAL | $6,611 | $5,716 | $5,085 | $4,892 | $16,620 |
| Total Liabilities And Equity | $46,905 | $53,020 | $47,027 | $40,188 | $45,189 |